Showing results (321-330 of 407) with videos related to
Sort By:
Pageof 41
Arthritis Research & Therapy|January 24, 2019
The need for comparative data in spondyloarthritisErnest Choy, Xenofon Baraliakos, Frank Behrens, et al.Journal of the American Academy of Dermatology|August 29, 2013
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinicsPhilip J Mease, Dafna D Gladman, Kim A Papp, et al.Rheumatology and Therapy|July 3, 2023
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic ArthritisBruce W Kirkham, Alexander Egeberg, Frank Behrens, et al.The Lancet. Rheumatology|January 30, 2024
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 studyLaura C Coates, William Tillett, Maria-Antonietta D'Agostino, et al.Annals of the Rheumatic Diseases|June 7, 2020
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2Robert Bm Landewé, Pedro M Machado, Féline Kroon, et al.Journal of Clinical Medicine|July 14, 2023
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid ArthritisThomas Häupl, Till Sörensen, Biljana Smiljanovic, et al.Frontiers in Medicine|November 7, 2025
Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot studyStephanie Dauth, Stephan M G Schäfer, Maximilian Klippstein, et al.Rheumatology and Therapy|March 18, 2024
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical TrialLars Erik Kristensen, Mauro Keiserman, Kim Papp, et al.Annals of the Rheumatic Diseases|March 30, 2007
Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritisFrank Behrens, Andrea Himsel, Stefan Rehart, et al.Arthritis Care & Research|January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease ManifestationsPhilip J Mease, Dafna D Gladman, Alexis Ogdie, et al.Pageof 41